Clinical trials sponsored by China National Center for Cardiovascular Diseases

Phase breakdown

Conditions studied

Recruiting trials led by China National Center for Cardiovascular Diseases

• A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
  NCT06554301 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Calcium-Phosphorus Regulation Therapy on Heart Valve Disease
  NCT06660524 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Cerebral Microembolization Associated With PFO Closure
  NCT06347276 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
  NCT05610215 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Consistency of LGE-MRI Fibrosis and EAM Low-voltage Area
  NCT06552845 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Corheart 6: Long-term Cohort Study
  NCT07094919 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
  NCT06615596 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass
  NCT04220047 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
  NCT06055452 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Goal Setting and Mobile-based Self-management Tool to Improve Diet Quality of People With High Blood Pressure
  NCT06988501 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 70 Years · Sex: All (male and female) · 1 location
• Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial
  NCT06828692 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 79 Years · Sex: All (male and female) · 1 location
• Internal Microstructure of Patent Foramen Ovale Related to Stroke
  NCT04686253 · Phase: Not specified · Ages: 16 Years to 65 Years · Sex: All (male and female) · 2 locations
• LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.
  NCT06021808 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
  NCT06108414 · Phase: Phase 4 · Ages: 70 Years and older · Sex: All (male and female) · 1 location
• Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
  NCT06932874 · Phase: Phase 4 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension
  NCT06429579 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Months to 18 Years · Sex: All (male and female) · 1 location
• Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
  NCT07400549 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
  NCT07601763 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Registration Study for Rare Type of Pulmonary Hypertension
  NCT03169010 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
  NCT05598632 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
  NCT05372263 · Phase: Not specified · Ages: 3 Months to 85 Years · Sex: All (male and female) · 1 location
• Unipolar Voltage Mapping for Personalized Atrial Fibrillation Ablation
  NCT07630857 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is China National Center for Cardiovascular Diseases recruiting for?

China National Center for Cardiovascular Diseases is the lead sponsor of 22 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.